184 related articles for article (PubMed ID: 8016148)
41. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
42. Cytokines and cytokine receptors in acute lymphoblastic leukemia expressing myeloid markers--role in growth regulation.
Komada Y; Sakurai M
Leuk Lymphoma; 1994 Nov; 15(5-6):411-8. PubMed ID: 7873998
[TBL] [Abstract][Full Text] [Related]
43. Cytokines and the central nervous system.
Szelényi J
Brain Res Bull; 2001 Mar; 54(4):329-38. PubMed ID: 11306183
[TBL] [Abstract][Full Text] [Related]
44. The development of cytokine receptor antagonists as potential therapeutic agents for the myeloproliferative disorders.
Ramshaw H; Lopez A; Bardy P
Curr Pharm Des; 2002; 8(5):357-68. PubMed ID: 12069374
[TBL] [Abstract][Full Text] [Related]
45. Cytokines and related receptor-mediated signaling pathways.
Haddad JJ
Biochem Biophys Res Commun; 2002 Oct; 297(4):700-13. PubMed ID: 12359210
[TBL] [Abstract][Full Text] [Related]
46. Evolution of Cytokine Receptor Signaling.
Liongue C; Sertori R; Ward AC
J Immunol; 2016 Jul; 197(1):11-8. PubMed ID: 27317733
[TBL] [Abstract][Full Text] [Related]
47. Cytokines in hematopoiesis.
Alexander WS
Int Rev Immunol; 1998; 16(5-6):651-82. PubMed ID: 9646181
[TBL] [Abstract][Full Text] [Related]
48. The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex.
Jones SA; Rose-John S
Biochim Biophys Acta; 2002 Nov; 1592(3):251-63. PubMed ID: 12421670
[TBL] [Abstract][Full Text] [Related]
49. Cytokine cross-talk between phagocytic cells and lymphocytes: relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity.
Trinchieri G; Kubin M; Bellone G; Cassatella MA
J Cell Biochem; 1993 Dec; 53(4):301-8. PubMed ID: 8300747
[TBL] [Abstract][Full Text] [Related]
50. Modulation of pro-inflammatory cytokine biology by unsaturated fatty acids.
Grimble RF; Tappia PS
Z Ernahrungswiss; 1998; 37 Suppl 1():57-65. PubMed ID: 9558730
[TBL] [Abstract][Full Text] [Related]
51. Is interleukin 17, an inducible cytokine that stimulates production of other cytokines, merely a redundant player in a sea of other biomolecules?
Broxmeyer HE
J Exp Med; 1996 Jun; 183(6):2411-5. PubMed ID: 8676060
[No Abstract] [Full Text] [Related]
52. Transforming growth factor beta and interleukin-1: a paradigm for opposing regulation of haemopoiesis.
Ruscetti FW; Dubois CM; Jacobsen SE; Keller JR
Baillieres Clin Haematol; 1992 Jul; 5(3):703-21. PubMed ID: 1333850
[TBL] [Abstract][Full Text] [Related]
53. Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine network.
Castor CW; Smith EM; Bignall MC; Hossler PA
J Rheumatol; 1997 Nov; 24(11):2080-9. PubMed ID: 9375864
[TBL] [Abstract][Full Text] [Related]
54. Histamine-cytokine connection in immunity and hematopoiesis.
Dy M; Schneider E
Cytokine Growth Factor Rev; 2004 Oct; 15(5):393-410. PubMed ID: 15450254
[TBL] [Abstract][Full Text] [Related]
55. Hematopoietic modulation by the tachykinins.
Rameshwar P; Gascón P
Acta Haematol; 1997; 98(2):59-64. PubMed ID: 9286300
[TBL] [Abstract][Full Text] [Related]
56. The future of cytokine combination therapy.
Moore MA
Cancer; 1991 May; 67(10 Suppl):2718-26. PubMed ID: 2015575
[TBL] [Abstract][Full Text] [Related]
57. Pathophysiological role of the cytokine network in the anterior pituitary gland.
Arzt E; Pereda MP; Castro CP; Pagotto U; Renner U; Stalla GK
Front Neuroendocrinol; 1999 Jan; 20(1):71-95. PubMed ID: 9882537
[TBL] [Abstract][Full Text] [Related]
58. Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules.
Contasta I; Pellegrini P; Berghella AM; Adorno D
Cancer Biother Radiopharm; 2001 Feb; 16(1):63-71. PubMed ID: 11279799
[TBL] [Abstract][Full Text] [Related]
59. The receptors for regulatory molecules of hematopoiesis.
Olsson I; Gullberg U; Lantz M; Richter J
Eur J Haematol; 1992 Jan; 48(1):1-9. PubMed ID: 1730275
[TBL] [Abstract][Full Text] [Related]
60. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
